Prelude Therapeutics Inc (PRLD)

Jan 06, 2026

Prelude Therapeutics Reshapes Pipeline With Incyte Deal and Strategic Refocus - MSN

Jan 06, 2026

Dec 31, 2025

Prelude Therapeutics Incorporated (NASDAQ:PRLD) Short Interest Up 28.5% in December - MarketBeat

Dec 31, 2025

Dec 30, 2025

Bullish Prelude Therapeutics Insiders Rewarded As Their Investment Rises To US$2.75m - Sahm

Dec 30, 2025

Dec 29, 2025

Prelude Therapeutics Incorporated's (NASDAQ:PRLD) Path To Profitability - Yahoo Finance

Dec 29, 2025

Dec 25, 2025

Prelude Therapeutics (NASDAQ:PRLD) Stock Price Up 2.1%What's Next? - MarketBeat

Dec 25, 2025

Dec 20, 2025

How Prelude Therapeutics Incorporated stock compares to industry benchmarksJuly 2025 Retail & Step-by-Step Trade Execution Guides - Улправда

Dec 20, 2025

Dec 20, 2025

What dividend safety score for Prelude Therapeutics Incorporated stock2025 Key Lessons & Risk Controlled Swing Alerts - Улправда

Dec 20, 2025

Dec 19, 2025

How Prelude Therapeutics Incorporated stock responds to policy changesEarnings Overview Summary & Scalable Portfolio Growth Methods - Улправда

Dec 19, 2025

Dec 19, 2025

Risk Analysis: What technical signals suggest for Prelude Therapeutics Incorporated stockForecast Cut & High Yield Stock Recommendations - Улправда

Dec 19, 2025

Dec 19, 2025

Is Prelude Therapeutics Incorporated stock a buy before product launches2025 Price Action Summary & Technical Pattern Based Signals - Улправда

Dec 19, 2025

Dec 19, 2025

Trend Report: Can Prelude Therapeutics Incorporated stock resist market sell offsJuly 2025 Setups & Free High Return Stock Watch Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Is Prelude Therapeutics Incorporated stock positioned well for digital economyPrice Action & Technical Confirmation Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Is Prelude Therapeutics Incorporated stock overvalued by current metricsVolume Spike & Long-Term Investment Growth Plans - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Prelude Therapeutics Incorporated stock reach all time highs in 2025Earnings Recap Report & Smart Swing Trading Techniques - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Will Prelude Therapeutics Incorporated stock pay special dividends2025 Dividend Review & Daily Profit Maximizing Tips - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Can Prelude Therapeutics Incorporated stock sustain revenue growthJuly 2025 News Drivers & Fast Gain Swing Trade Alerts - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Why Prelude Therapeutics Incorporated stock attracts global investors2025 Dividend Review & Daily Profit Maximizing Tips - Bölüm Sonu Canavarı

Dec 19, 2025

Dec 18, 2025

What technical signals suggest for Prelude Therapeutics Incorporated stockJuly 2025 EndofMonth & Weekly Return Optimization Plans - Улправда

Dec 18, 2025

Dec 18, 2025

Is Prelude Therapeutics Incorporated stock a buy for dividend growthJuly 2025 Closing Moves & Weekly Top Gainers Trade List - Улправда

Dec 18, 2025

Dec 18, 2025

Prelude Therapeutics Earnings Notes - Trefis

Dec 18, 2025

Dec 16, 2025

Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards - GlobeNewswire

Dec 16, 2025

Dec 10, 2025

Prelude Therapeutics divulges new JAK2 inhibitors - BioWorld MedTech

Dec 10, 2025

Dec 10, 2025

It makes sense and dollars to buy Prelude Therapeutics Inc (PRLD) stock - setenews.com

Dec 10, 2025

Dec 09, 2025

Prelude Therapeutics presents data at 2025 ASH meeting from MPN programs - MSN

Dec 09, 2025

Dec 08, 2025

Prelude Therapeutics stock rating reiterated at Market Outperform by Citizens - Investing.com Canada

Dec 08, 2025

Dec 07, 2025

Prelude Therapeutics (PRLD) Reveals Promising Preclinical Data a - GuruFocus

Dec 07, 2025

Dec 06, 2025

Prelude Therapeutics Unveils Promising Preclinical Data for JAK2V617F-selective JH2 Inhibitor and mCALR-targeted Degrader Antibody Conjugate at ASH 2025 - Quiver Quantitative

Dec 06, 2025

Dec 06, 2025

Prelude Therapeutics Presents Data at the 2025 ASH Annual - GlobeNewswire

Dec 06, 2025

Dec 06, 2025

Prelude Therapeutics (Nasdaq: PRLD) details MPN pipeline at 2025 ASH, eyes 2026 IND - Stock Titan

Dec 06, 2025

Dec 04, 2025

What insider trading reveals about Prelude Therapeutics Incorporated stockShort Setup & Daily Volume Surge Trade Alerts - Newser

Dec 04, 2025

Dec 01, 2025

Penny Stocks To Consider In December 2025 - simplywall.st

Dec 01, 2025

Nov 28, 2025

VIX Spike: How Prelude Therapeutics Incorporated stock compares to industry benchmarksJuly 2025 Decliners & Growth Focused Stock Pick Reports - moha.gov.vn

Nov 28, 2025

Nov 27, 2025

Growth Report: What dividend safety score for Prelude Therapeutics Incorporated stockJuly 2025 Big Picture & Daily Volume Surge Signals - moha.gov.vn

Nov 27, 2025

Nov 26, 2025

PRLD Investors Have Opportunity to Join Prelude - GlobeNewswire

Nov 26, 2025

Nov 25, 2025

This trade activity should not be overlooked: Prelude Therapeutics Inc (PRLD) - Setenews

Nov 25, 2025

Nov 24, 2025

Beat the Market the Zacks Way: Goldman Sachs, Micron, Prelude in Focus - TradingView — Track All Markets

Nov 24, 2025

Nov 21, 2025

Prelude Therapeutics Experiences Revision in Its Stock Evaluation Amid Mixed Financial Trends - Markets Mojo

Nov 21, 2025

Nov 20, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics IncorporatedPRLD - PR Newswire

Nov 20, 2025

Nov 19, 2025

Will Prelude Therapeutics Incorporated stock outperform Dow Jones indexJuly 2025 Sentiment & Smart Money Movement Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Is Prelude Therapeutics Incorporated stock supported by innovation pipeline2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

PRLD Investors Have Opportunity to Join Prelude Therapeutics Incorporated Fraud Investigation ... - Bakersfield.com

Nov 19, 2025

Nov 19, 2025

Prelude Therapeutics Incorporated (PRLD) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 19, 2025

Nov 19, 2025

What to do if you’re stuck in Prelude Therapeutics IncorporatedPortfolio Update Summary & Smart Investment Allocation Insights - newser.com

Nov 19, 2025

Nov 19, 2025

Targeted Cancer Therapies Gain Momentum as Precision Market Surges Past $106B - GlobeNewswire

Nov 19, 2025

Nov 19, 2025

Is Prelude Therapeutics Incorporated stock ready for a breakoutJuly 2025 Sector Moves & Weekly Market Pulse Updates - newser.com

Nov 19, 2025

Nov 19, 2025

What sentiment indicators say about Prelude Therapeutics Incorporated stock2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Prelude Advances Two Novel Cancer Programs as Cash Runway Extends Into 2027 - MyChesCo

Nov 19, 2025

Nov 18, 2025

Order flow analysis tools used on Prelude Therapeutics IncorporatedJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com

Nov 18, 2025

Nov 17, 2025

Can Prelude Therapeutics Incorporated stock hit analyst price targets2025 Geopolitical Influence & Fast Entry Momentum Trade Alerts - newser.com

Nov 17, 2025

Nov 17, 2025

Real time alert setup for Prelude Therapeutics Incorporated performanceProduct Launch & Safe Entry Trade Signal Reports - newser.com

Nov 17, 2025

Nov 17, 2025

Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com

Nov 17, 2025

Nov 17, 2025

Century Therapeutics Unveils iPSC Beta Islet Program as Cash Runway Extends Into 2027 - MyChesCo

Nov 17, 2025